Recursion Pharmaceuticals, Inc. Q1 FY2023 Earnings Call

Recursion Pharmaceuticals, Inc. (RXRX)

Earnings Call FY2023 Q1 Call date: 2023-05-08 Concluded

Quarter scorecard

Revenue

$12.13M

+127.5% YoY

Diluted EPS

$-0.34

Net income

-$65.33M

License And Service $12.13M

+129%

Grant $0

-100%